Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614211 · ClinicalTrials.gov registry record · NA
Laparoscopic Approach to Cervical Cancer
A NA study of Cervical Cancer, sponsored by Queensland Centre for Gynaecological Cancer.
- Completed
- Registry status
- NA
- Development phase
- 636
- Enrollment target
- 20
- Study locations
NCT00614211: Completed NA study of Cervical Cancer, sponsored by Queensland Centre for Gynaecological Cancer.
NCT00614211 is a NA study of Cervical Cancer that has completed, run by Queensland Centre for Gynaecological Cancer. The registered enrollment target is 636 participants, above the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target (12% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00614211, a NA study of Cervical Cancer, has completed, sponsored by Queensland Centre for Gynaecological Cancer.
- COMPLETED
- Registry status
- NA
- Development phase
- 636 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this clinical research study is to compare the long-term outcomes of different surgical methods for the treatment of cervical cancer. The long-term outcome of a total abdominal radical hysterectomy (TARH) will be compared against laparoscopy. In this study, the laparoscopy will be done with or without robotic technology.
Primary Outcome
Compare treatment equivalence
Conditions Studied
Interventions
- PROCEDURE Total Abdominal Radical Hysterectomy
- PROCEDURE Total Laparoscopic or Robotic Radical Hysterectomy
Study Locations (20)
Queensland
- The Wesley Hospital - Auchenflower
- Greenslopes Private Hospital - Greenslopes
- Royal Brisbane and Women's Hospital - Herston
- Mater Health Services - South Brisbane
- The Townsville Hospital - Townsville
São Paulo
- Barretos Cancer Hospital - Barretos
- Instituto Brasileiro de Controlle do Cancer - Brás
- Albert Einstein Hospital - Morumbi
Other
- Misericordia Hospital - Córdoba
- University Hospital Pleven Center of Oncology Gynaecology - Pleven
Maryland
- Greater Baltimore Medical Centre - Baltimore
Nevada
- Women's Cancer Centre Nevada - Las Vegas
New York
- St Luke's - Roosevelt Hospital Center - New York
Oklahoma
- Peggy and Charles Stephenson Oklahoma Cancer Center - Oklahoma City
Texas
- M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 636 participants |
| Start Date | 2008-01 |
| Est. Completion | 2022-03 |
| Phase | NA |
What the finished NCT00614211 record still lists
NCT00614211 is an interventional study that assigns participants to a tested intervention. The registered 636 participants enrollment target is mid-sized for trials with a published cap, above the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target (12% higher).
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which Total Abdominal Radical Hysterectomy is the first listed.
NCT00614211 names 20 study sites across 13 states, led by Queensland, São Paulo, Other.
Frequently Asked Questions
What is clinical trial NCT00614211 about?
NCT00614211 is a clinical study titled "Laparoscopic Approach to Cervical Cancer". The goal of this clinical research study is to compare the long-term outcomes of different surgical methods for the treatment of cervical cancer. The long-term outcome of a total abdominal radical hysterectomy (TARH) will be compared against laparoscopy. In this study, the laparoscopy will be done w...
What is the current status of trial NCT00614211?
This trial is currently completed. It is a NA study. The enrollment target is 636 participants. The study started on 2008-01. Estimated completion is 2022-03.
What conditions does trial NCT00614211 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT00614211?
The interventions under investigation include: Total Abdominal Radical Hysterectomy (PROCEDURE), Total Laparoscopic or Robotic Radical Hysterectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00614211?
This trial is sponsored by Queensland Centre for Gynaecological Cancer, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00614211 being conducted?
This trial has 20 study locations across Maryland, Nevada, New York, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00614211's enrollment target sits among peer trials
636 24th of 144 higher than 121 of 144 other Cervical Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821129 · 636 participants · NA
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia